{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:25:53Z","timestamp":1788607553998,"version":"build-2803163510"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T00:00:00Z","timestamp":1306454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2377-11-61","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T14:22:40Z","timestamp":1306506160000},"source":"Crossref","is-referenced-by-count":114,"title":["Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel"],"prefix":"10.1186","volume":"11","author":[{"given":"Alessandro P","family":"Burlina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine B","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M","family":"Politei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette Torvin","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J","family":"Hilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,27]]},"reference":[{"key":"470_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","volume":"64","author":"RJ Hopkin","year":"2008","unstructured":"Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, Lemay R, Tylki-Szymanska A, Wilcox WR: Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res. 2008, 64: 550-555. 10.1203\/PDR.0b013e318183f132.","journal-title":"Pediatr Res"},{"key":"470_CR2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08035250500275022","volume":"95","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassmann G, Widmer U, Beck M: Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr. 2006, 95: 86-92.","journal-title":"Acta Paediatr"},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ: Fabry's disease. Lancet. 2008, 372: 1427-1435. 10.1016\/S0140-6736(08)61589-5.","journal-title":"Lancet"},{"key":"470_CR4","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"R Desnick","year":"2001","unstructured":"Desnick R, Ioannou Y, Eng C: alpha-Galactosidase A deficiency: Fabry disease. The Metabolic and Molecular Bases of Inherited Disease. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. 2001, New York: McGraw-Hill, 3733-3774."},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(06)70548-8","volume":"5","author":"A Fellgiebel","year":"2006","unstructured":"Fellgiebel A, Muller MJ, Ginsberg L: CNS manifestations of Fabry's disease. Lancet Neurol. 2006, 5: 791-795. 10.1016\/S1474-4422(06)70548-8.","journal-title":"Lancet Neurol"},{"key":"470_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM: Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007, 28: 1228-1235. 10.1093\/eurheartj\/ehm153.","journal-title":"Eur Heart J"},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, Sorensen SA, Wilcox WR, Desnick RJ: Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant. 2009, 24: 2102-2111. 10.1093\/ndt\/gfp031.","journal-title":"Nephrol Dial Transplant"},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","volume":"40","author":"K Sims","year":"2009","unstructured":"Sims K, Politei J, Banikazemi M, Lee P: Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke. 2009, 40: 788-794. 10.1161\/STROKEAHA.108.526293.","journal-title":"Stroke"},{"key":"470_CR9","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.2215\/CJN.04340510","volume":"5","author":"C Wanner","year":"2010","unstructured":"Wanner C, Oliveira JP, Ortiz A, Mauer M, Germain DP, Linthorst GE, Serra AL, Marodi L, Mignani R, Cianciaruso B, Vujkovac B, Lemay R, Beitner-Johnson D, Waldek S, Warnock DG: Prognostic indicators of renal disease progression in adults with Fabry disease: Natural history data from the Fabry Registry. Clin J Am Soc Nephrol. 2010, 5: 2220-2228. 10.2215\/CJN.04340510.","journal-title":"Clin J Am Soc Nephrol"},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP: Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab. 2008, 93: 112-128. 10.1016\/j.ymgme.2007.09.013.","journal-title":"Mol Genet Metab"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","volume":"9","author":"RY Wang","year":"2007","unstructured":"Wang RY, Lelis A, Mirocha J, Wilcox WR: Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med. 2007, 9: 34-45. 10.1097\/GIM.0b013e31802d8321.","journal-title":"Genet Med"},{"key":"470_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1651-2227.2002.tb03110.x","volume":"91","author":"R Schiffmann","year":"2002","unstructured":"Schiffmann R, Scott LJ: Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl. 2002, 91: 48-52.","journal-title":"Acta Paediatr Suppl"},{"key":"470_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncpneuro0407","volume":"3","author":"AT Moller","year":"2007","unstructured":"Moller AT, Jensen TS: Neurological manifestations in Fabry's disease. Nat Clin Pract Neurol. 2007, 3: 95-106. 10.1038\/ncpneuro0407.","journal-title":"Nat Clin Pract Neurol"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1445-5994.2007.01366.x","volume":"37","author":"M Low","year":"2007","unstructured":"Low M, Nicholls K, Tubridy N, Hand P, Velakoulis D, Kiers L, Mitchell P, Becker G: Neurology of Fabry disease. Intern Med J. 2007, 37: 436-447. 10.1111\/j.1445-5994.2007.01366.x.","journal-title":"Intern Med J"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ: Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA. 2008, 105: 2812-2817. 10.1073\/pnas.0712309105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"470_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.32.4.347","volume":"32","author":"WJ Cable","year":"1982","unstructured":"Cable WJ, Dvorak AM, Osage JE, Kolodny EH: Fabry disease: significance of ultrastructural localization of lipid inclusions in dermal nerves. Neurology. 1982, 32: 347-353.","journal-title":"Neurology"},{"key":"470_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","volume":"32","author":"WJ Cable","year":"1982","unstructured":"Cable WJ, Kolodny EH, Adams RD: Fabry disease: impaired autonomic function. Neurology. 1982, 32: 498-502.","journal-title":"Neurology"},{"key":"470_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00685960","volume":"33","author":"N Fukuhara","year":"1975","unstructured":"Fukuhara N, Suzuki M, Fujita N, Tsubaki T: Fabry's disease on the mechanism of the peripheral nerve involvement. Acta Neuropathol. 1975, 33: 9-21. 10.1007\/BF00685960.","journal-title":"Acta Neuropathol"},{"key":"470_CR19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archneur.1970.00480190085014","volume":"22","author":"RS Kocen","year":"1970","unstructured":"Kocen RS, Thomas PK: Peripheral nerve involvement in Fabry's disease. Arch Neurol. 1970, 22: 81-88.","journal-title":"Arch Neurol"},{"key":"470_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/mus.880040506","volume":"4","author":"JF Pellissier","year":"1981","unstructured":"Pellissier JF, Van Hoof F, Bourdet-Bonerandi D, Monier-Faugere MC, Toga M: Morphological and biochemical changes in muscle and peripheral nerve in Fabry's disease. Muscle Nerve. 1981, 4: 381-387. 10.1002\/mus.880040506.","journal-title":"Muscle Nerve"},{"key":"470_CR21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archneur.1978.00500290037007","volume":"35","author":"AA Sima","year":"1978","unstructured":"Sima AA, Robertson DM: Involvement of peripheral nerve and muscle in Fabry's disease. Histologic, ultrastructural, and morphometric studies. Arch Neurol. 1978, 35: 291-301.","journal-title":"Arch Neurol"},{"key":"470_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","volume":"122","author":"BL Thurberg","year":"2004","unstructured":"Thurberg BL, Randolph Byers H, Granter SR, Phelps RG, Gordon RE, O'Callaghan M: Monitoring the 3-year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies. J Invest Dermatol. 2004, 122: 900-908. 10.1111\/j.0022-202X.2004.22425.x.","journal-title":"J Invest Dermatol"},{"key":"470_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s004150050125","volume":"244","author":"K Toyooka","year":"1997","unstructured":"Toyooka K, Said G: Nerve biopsy findings in hemizygous and heterozygous patients with Fabry's disease. J Neurol. 1997, 244: 464-468. 10.1007\/s004150050125.","journal-title":"J Neurol"},{"key":"470_CR24","first-page":"168","volume":"3","author":"A Vital","year":"1984","unstructured":"Vital A, Vital C, Maleville J: Fabry's disease: an ultrastructural study of muscle and peripheral nerve. Clin Neuropathol. 1984, 3: 168-172.","journal-title":"Clin Neuropathol"},{"key":"470_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpeds.2007.09.007","volume":"152","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Tylki-Szymanska A, Guffon N, Lien YH, Tsimaratos M, Vellodi A, Germain DP: Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease. J Pediatr. 2008, 152: 563-570. 10.1016\/j.jpeds.2007.09.007.","journal-title":"J Pediatr"},{"key":"470_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ana.410230513","volume":"23","author":"EM Kaye","year":"1988","unstructured":"Kaye EM, Kolodny EH, Logigian EL, Ullman MD: Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol. 1988, 23: 505-509. 10.1002\/ana.410230513.","journal-title":"Ann Neurol"},{"key":"470_CR27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0022-3565(25)29710-5","volume":"187","author":"GG Somjen","year":"1973","unstructured":"Somjen GG, Herman SP, Klein R, Brubaker PE, Briner WH, Goodrich JK, Krigman MR, Haseman JK: The uptake of methyl mercury (203 Hg) in different tissues related to its neurotoxic effects. J Pharmacol Exp Ther. 1973, 187: 602-611.","journal-title":"J Pharmacol Exp Ther"},{"key":"470_CR28","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","volume":"32","author":"G Altarescu","year":"2001","unstructured":"Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, Panza JA, Schiffmann R: Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke. 2001, 32: 1559-1562.","journal-title":"Stroke"},{"key":"470_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","volume":"47","author":"T DeGraba","year":"2000","unstructured":"DeGraba T, Azhar S, Dignat-George F, Brown E, Boutiere B, Altarescu G, McCarron R, Schiffmann R: Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000, 47: 229-233. 10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T.","journal-title":"Ann Neurol"},{"key":"470_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncpneuro0113","volume":"2","author":"R Baron","year":"2006","unstructured":"Baron R: Mechanisms of disease: neuropathic pain--a clinical perspective. Nat Clin Pract Neurol. 2006, 2: 95-106. 10.1038\/ncpneuro0113.","journal-title":"Nat Clin Pract Neurol"},{"key":"470_CR31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1651-2227.2002.tb03107.x","volume":"91","author":"F Birklein","year":"2002","unstructured":"Birklein F: Mechanisms of neuropathic pain and their importance in Fabry disease. Acta Paediatr Suppl. 2002, 91: 34-37.","journal-title":"Acta Paediatr Suppl"},{"key":"470_CR32","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ, Brady RO: Fabry disease in childhood. J Pediatr. 2004, 144: S20-26. 10.1016\/j.jpeds.2004.01.051.","journal-title":"J Pediatr"},{"key":"470_CR33","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1742-1241.2006.01061.x","volume":"60","author":"O Lidove","year":"2006","unstructured":"Lidove O, Ramaswami U, Jaussaud R, Barbey F, Maisonobe T, Caillaud C, Beck M, Sunder-Plassmann G, Linhart A, Mehta A: Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. Int J Clin Pract. 2006, 60: 1053-1059. 10.1111\/j.1742-1241.2006.01061.x.","journal-title":"Int J Clin Pract"},{"key":"470_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0304-3959(99)00236-5","volume":"84","author":"MJ Hilz","year":"2000","unstructured":"Hilz MJ, Stemper B, Kolodny EH: Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain. 2000, 84: 361-365. 10.1016\/S0304-3959(99)00236-5.","journal-title":"Pain"},{"key":"470_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mus.20130","volume":"31","author":"D Lacomis","year":"2005","unstructured":"Lacomis D, Roeske-Anderson L, Mathie L: Neuropathy and Fabry's disease. Muscle Nerve. 2005, 31: 102-107. 10.1002\/mus.20130.","journal-title":"Muscle Nerve"},{"key":"470_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mus.10236","volume":"26","author":"CA Luciano","year":"2002","unstructured":"Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, Barton NW, Schiffmann R: Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve. 2002, 26: 622-629. 10.1002\/mus.10236.","journal-title":"Muscle Nerve"},{"key":"470_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2002.tb03108.x","volume":"91","author":"MJ Hilz","year":"2002","unstructured":"Hilz MJ: Evaluation of peripheral and autonomic nerve function in Fabry disease. Acta Paediatr Suppl. 2002, 91: 38-42.","journal-title":"Acta Paediatr Suppl"},{"key":"470_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001, 38: 769-775. 10.1136\/jmg.38.11.769.","journal-title":"J Med Genet"},{"key":"470_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2009.06.032","volume":"145","author":"A Torvin M\u00f8ller","year":"2009","unstructured":"Torvin M\u00f8ller A, Winther Bach F, Feldt-Rasmussen U, Rasmussen A, Hasholt L, Lan H, Sommer C, Kolvraa S, Ballegaard M, Staehelin Jensen T: Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain. 2009, 145: 237-245. 10.1016\/j.pain.2009.06.032.","journal-title":"Pain"},{"key":"470_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","volume":"19","author":"M D\u00fctsch","year":"2002","unstructured":"D\u00fctsch M, Marthol H, Stemper B, Brys M, Haendl T, Hilz MJ: Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol. 2002, 19: 575-586. 10.1097\/00004691-200212000-00011.","journal-title":"J Clin Neurophysiol"},{"key":"470_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/mus.20174","volume":"30","author":"M Valeriani","year":"2004","unstructured":"Valeriani M, Mariotti P, Le Pera D, Restuccia D, De Armas L, Maiese T, Vigevano F, Antuzzi D, Zampino G, Ricci R, Tonali P: Functional assessment of A delta and C fibers in patients with Fabry's disease. Muscle Nerve. 2004, 30: 708-713. 10.1002\/mus.20174.","journal-title":"Muscle Nerve"},{"key":"470_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2362.2008.01921.x","volume":"38","author":"F Weidemann","year":"2008","unstructured":"Weidemann F, Strotmann JM, Breunig F, Niemann M, Maag R, Baron R, Eggert AO, Wanner C: Misleading terms in Anderson-Fabry disease. Eur J Clin Invest. 2008, 38: 191-196. 10.1111\/j.1365-2362.2008.01921.x.","journal-title":"Eur J Clin Invest"},{"key":"470_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1023\/A:1015511908710","volume":"11","author":"KF Gold","year":"2002","unstructured":"Gold KF, Pastores GM, Botteman MF, Yeh JM, Sweeney S, Aliski W, Pashos CL: Quality of life of patients with Fabry disease. Qual Life Res. 2002, 11: 317-327. 10.1023\/A:1015511908710.","journal-title":"Qual Life Res"},{"key":"470_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/01.gim.0000223545.63012.5a","volume":"8","author":"NJ Street","year":"2006","unstructured":"Street NJ, Yi MS, Bailey LA, Hopkin RJ: Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med. 2006, 8: 346-353. 10.1097\/01.gim.0000223545.63012.5a.","journal-title":"Genet Med"},{"key":"470_CR45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/GIM.0b013e3181f13a4a","volume":"12","author":"T Watt","year":"2010","unstructured":"Watt T, Burlina AP, Cazzorla C, Schonfeld D, Banikazemi M, Hopkin RJ, Martins AM, Sims K, Beitner-Johnson D, O'Brien F, Feldt-Rasmussen U: Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry. Genet Med. 2010, 12: 703-712.","journal-title":"Genet Med"},{"key":"470_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS: Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007, 132: 237-251. 10.1016\/j.pain.2007.08.033.","journal-title":"Pain"},{"key":"470_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10545-009-1254-1","volume":"32","author":"TW Crosbie","year":"2009","unstructured":"Crosbie TW, Packman W, Packman S: Psychological aspects of patients with Fabry disease. J Inherit Metab Dis. 2009, 32: 745-753. 10.1007\/s10545-009-1254-1.","journal-title":"J Inherit Metab Dis"},{"key":"470_CR48","unstructured":"Laney DA, Gruskin DJ, Fernhoff PM, Cubells JF, Ousley OY, Hipp H, Mehta AJ: Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis."},{"key":"470_CR49","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10545-007-0708-6","volume":"30","author":"AL Cole","year":"2007","unstructured":"Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH: Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis. 2007, 30: 943-951. 10.1007\/s10545-007-0708-6.","journal-title":"J Inherit Metab Dis"},{"key":"470_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2190\/JKFW-3WXK-QA7N-BYLN","volume":"23","author":"RP Grewal","year":"1993","unstructured":"Grewal RP: Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med. 1993, 23: 307-312. 10.2190\/JKFW-3WXK-QA7N-BYLN.","journal-title":"Int J Psychiatry Med"},{"key":"470_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00041444-200412000-00006","volume":"14","author":"J Sadek","year":"2004","unstructured":"Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J: Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet. 2004, 14: 199-201. 10.1097\/00041444-200412000-00006.","journal-title":"Psychiatr Genet"},{"key":"470_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/mus.10181","volume":"26","author":"D Lacomis","year":"2002","unstructured":"Lacomis D: Small-fiber neuropathy. Muscle Nerve. 2002, 26: 173-188. 10.1002\/mus.10181.","journal-title":"Muscle Nerve"},{"key":"470_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1468-1331.2010.03227.x","volume":"18","author":"C Tanislav","year":"2011","unstructured":"Tanislav C, Kaps M, Rolfs A, Bottcher T, Lackner K, Paschke E, Mascher H, Laue M, Blaes F: Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study. Eur J Neurol. 2011, 18: 631-636. 10.1111\/j.1468-1331.2010.03227.x.","journal-title":"Eur J Neurol"},{"key":"470_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/mus.21606","volume":"41","author":"R Liguori","year":"2010","unstructured":"Liguori R, Di Stasi V, Bugiardini E, Mignani R, Burlina A, Borsini W, Baruzzi A, Montagna P, Donadio V: Small fiber neuropathy in female patients with fabry disease. Muscle Nerve. 2010, 41: 409-412. 10.1002\/mus.21606.","journal-title":"Muscle Nerve"},{"key":"470_CR55","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.clinph.2008.02.004","volume":"119","author":"SM Laaksonen","year":"2008","unstructured":"Laaksonen SM, Roytta M, Jaaskelainen SK, Kantola I, Penttinen M, Falck B: Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol. 2008, 119: 1365-1372. 10.1016\/j.clinph.2008.02.004.","journal-title":"Clin Neurophysiol"},{"key":"470_CR56","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1526-4637.2008.00470.x","volume":"9","author":"R Maag","year":"2008","unstructured":"Maag R, Binder A, Maier C, Scherens A, Toelle T, Treede RD, Baron R: Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. Pain Med. 2008, 9: 1217-1223. 10.1111\/j.1526-4637.2008.00470.x.","journal-title":"Pain Med"},{"key":"470_CR57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archneur.1974.00490380068009","volume":"31","author":"A Onishi","year":"1974","unstructured":"Onishi A, Dyck PJ: Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol. 1974, 31: 120-127.","journal-title":"Arch Neurol"},{"key":"470_CR58","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/(SICI)1097-4598(199911)22:11<1531::AID-MUS7>3.0.CO;2-O","volume":"22","author":"LS Ro","year":"1999","unstructured":"Ro LS, Chen ST, Tang LM, Hsu WC, Chang HS, Huang CC: Current perception threshold testing in Fabry's disease. Muscle Nerve. 1999, 22: 1531-1537. 10.1002\/(SICI)1097-4598(199911)22:11<1531::AID-MUS7>3.0.CO;2-O.","journal-title":"Muscle Nerve"},{"key":"470_CR59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.52.6.1249","volume":"52","author":"LJ Scott","year":"1999","unstructured":"Scott LJ, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, McArthur JC, Tournay A, Schiffmann R: Quantitative analysis of epidermal innervation in Fabry disease. Neurology. 1999, 52: 1249-1254.","journal-title":"Neurology"},{"key":"470_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1085-9489.2006.00076.x","volume":"11","author":"AT Moller","year":"2006","unstructured":"Moller AT, Feldt-Rasmussen U, Rasmussen AK, Sommer C, Hasholt L, Bach FW, Kolvraa S, Jensen TS: Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin. J Peripher Nerv Syst. 2006, 11: 119-125. 10.1111\/j.1085-9489.2006.00076.x.","journal-title":"J Peripher Nerv Syst"},{"key":"470_CR61","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/1097-4598(200008)23:8<1179::AID-MUS4>3.0.CO;2-7","volume":"23","author":"NA Syed","year":"2000","unstructured":"Syed NA, Sandbrink F, Luciano CA, Altarescu G, Weibel T, Schiffmann R, Floeter MK: Cutaneous silent periods in patients with Fabry disease. Muscle Nerve. 2000, 23: 1179-1186. 10.1002\/1097-4598(200008)23:8<1179::AID-MUS4>3.0.CO;2-7.","journal-title":"Muscle Nerve"},{"key":"470_CR62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0079-6123(08)64343-5","volume":"43","author":"H Hensel","year":"1976","unstructured":"Hensel H: Functional and structural basis of thermoreception. Prog Brain Res. 1976, 43: 105-118.","journal-title":"Prog Brain Res"},{"key":"470_CR63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/jnnp.45.4.313","volume":"45","author":"RG Hallin","year":"1982","unstructured":"Hallin RG, Torebjork HE, Wiesenfeld Z: Nociceptors and warm receptors innervated by C fibres in human skin. J Neurol Neurosurg Psychiatry. 1982, 45: 313-319. 10.1136\/jnnp.45.4.313.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"470_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/B978-0-08-021208-1.50028-X","volume-title":"Sensory functions of the skin in primates with special reference to man","author":"DR Kenshalo","year":"1976","unstructured":"Kenshalo DR: Correlations of temperature sensitivity in man and monkey, a first approximation. Sensory functions of the skin in primates with special reference to man. Edited by: Zottermann Y. 1976, Oxford: Pergamon Press, 305-330."},{"key":"470_CR65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/brain\/awl310","volume":"130","author":"M Ries","year":"2007","unstructured":"Ries M, Kim HJ, Zalewski CK, Mastroianni MA, Moore DF, Brady RO, Dambrosia JM, Schiffmann R, Brewer CC: Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain. 2007, 130: 143-150.","journal-title":"Brain"},{"key":"470_CR66","first-page":"491","volume":"75","author":"SH Morgan","year":"1990","unstructured":"Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, Young EP, Crawfurd MD, Bannister R: The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. Q J Med. 1990, 75: 491-507.","journal-title":"Q J Med"},{"key":"470_CR67","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0149-2918(07)80119-6","volume":"29","author":"MJ Hilz","year":"2007","unstructured":"Hilz MJ: Peripheral nervous system involvement in Fabry disease: role in morbidity and mortality. Clin Ther. 2007, 29: S11-12.","journal-title":"Clin Ther"},{"key":"470_CR68","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1097\/HJH.0b013e328336a077","volume":"28","author":"MJ Hilz","year":"2010","unstructured":"Hilz MJ, Marthol H, Schwab S, Kolodny EH, Brys M, Stemper B: Enzyme replacement therapy improves cardiovascular responses to orthostatic challenge in Fabry patients. J Hypertens. 2010, 28: 1438-1448. 10.1097\/HJH.0b013e328336a077.","journal-title":"J Hypertens"},{"key":"470_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","volume":"122","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R: Fabry disease. Pharmacol Ther. 2009, 122: 65-77. 10.1016\/j.pharmthera.2009.01.003.","journal-title":"Pharmacol Ther"},{"key":"470_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0923-1811(98)00032-2","volume":"18","author":"LM Lao","year":"1998","unstructured":"Lao LM, Kumakiri M, Mima H, Kuwahara H, Ishida H, Ishiguro K, Fujita T, Ueda K: The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci. 1998, 18: 109-117. 10.1016\/S0923-1811(98)00032-2.","journal-title":"J Dermatol Sci"},{"key":"470_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2377-10-38","volume":"10","author":"M Biegstraaten","year":"2010","unstructured":"Biegstraaten M, van Schaik IN, Wieling W, Wijburg FA, Hollak CE: Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests. BMC Neurology. 2010, 10: 38-10.1186\/1471-2377-10-38.","journal-title":"BMC Neurology"},{"key":"470_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0022-510X(03)00172-2","volume":"214","author":"I Gomes","year":"2003","unstructured":"Gomes I, Nora DB, Becker J, Ehlers JA, Schwartz IV, Giugliani R, Ashton-Prolla P, Jardim L: Nerve conduction studies, electromyography and sympathetic skin response in Fabry's disease. J Neurol Sci. 2003, 214: 21-25. 10.1016\/S0022-510X(03)00172-2.","journal-title":"J Neurol Sci"},{"key":"470_CR73","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","volume":"62","author":"MJ Hilz","year":"2004","unstructured":"Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M: Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology. 2004, 62: 1066-1072.","journal-title":"Neurology"},{"key":"470_CR74","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jnnp.42.9.793","volume":"42","author":"JM Goldberg","year":"1979","unstructured":"Goldberg JM, Lindblom U: Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry. 1979, 42: 793-803. 10.1136\/jnnp.42.9.793.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"470_CR75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0404.1985.tb03201.x","volume":"71","author":"R Tegner","year":"1985","unstructured":"Tegner R, Lindholm B: Vibratory perception threshold compared with nerve conduction velocity in the evaluation of uremic neuropathy. Acta Neurol Scand. 1985, 71: 284-289.","journal-title":"Acta Neurol Scand"},{"key":"470_CR76","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0002-9343(73)90140-X","volume":"55","author":"RC Pabico","year":"1973","unstructured":"Pabico RC, Atancio BC, McKenna BA, Pamukcoglu T, Yodaiken R: Renal pathologic lesions and functional alterations in a man with Fabry's disease. Am J Med. 1973, 55: 415-425. 10.1016\/0002-9343(73)90140-X.","journal-title":"Am J Med"},{"key":"470_CR77","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","volume":"156","author":"CL Marchesoni","year":"2010","unstructured":"Marchesoni CL, Roa N, Pardal AM, Neumann P, Caceres G, Martinez P, Kisinovsky I, Bianchi S, Tarabuso AL, Reisin RC: Misdiagnosis in Fabry disease. J Pediatr. 2010, 156: 828-831. 10.1016\/j.jpeds.2010.02.012.","journal-title":"J Pediatr"},{"key":"470_CR78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.49.1.229","volume":"49","author":"PJ Dyck","year":"1997","unstructured":"Dyck PJ, Davies JL, Litchy WJ, O'Brien PC: Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997, 49: 229-239.","journal-title":"Neurology"},{"key":"470_CR79","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pain.2006.10.034","volume":"127","author":"MI Bennett","year":"2007","unstructured":"Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tolle TR, Wittchen HU, Jensen TS: Using screening tools to identify neuropathic pain. Pain. 2007, 127: 199-203. 10.1016\/j.pain.2006.10.034.","journal-title":"Pain"},{"key":"470_CR80","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/BF00400603","volume":"38","author":"D Ziegler","year":"1995","unstructured":"Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schutte K, Gries FA: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995, 38: 1425-1433. 10.1007\/BF00400603.","journal-title":"Diabetologia"},{"key":"470_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2009.02.007","volume":"144","author":"RH Dworkin","year":"2009","unstructured":"Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R: Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009, 144: 35-42. 10.1016\/j.pain.2009.02.007.","journal-title":"Pain"},{"key":"470_CR82","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.pcl.2009.05.016","volume":"56","author":"JW Varni","year":"2009","unstructured":"Varni JW, Limbers CA: The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatr Clin North Am. 2009, 56: 843-863. 10.1016\/j.pcl.2009.05.016.","journal-title":"Pediatr Clin North Am"},{"key":"470_CR83","doi-asserted-by":"crossref","unstructured":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996, 46: 1470-","DOI":"10.1212\/WNL.46.5.1470"},{"key":"470_CR84","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","volume":"53","author":"N Samiy","year":"2008","unstructured":"Samiy N: Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder. Surv Ophthalmol. 2008, 53: 416-423. 10.1016\/j.survophthal.2008.04.005.","journal-title":"Surv Ophthalmol"},{"key":"470_CR85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2215\/CJN.08091109","volume":"5","author":"U Ramaswami","year":"2010","unstructured":"Ramaswami U, Najafian B, Schieppati A, Mauer M, Bichet DG: Assessment of renal pathology and dysfunction in children with Fabry disease. Clin J Am Soc Nephrol. 2010, 5: 365-370. 10.2215\/CJN.08091109.","journal-title":"Clin J Am Soc Nephrol"},{"key":"470_CR86","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.24.4.325","volume":"24","author":"PJ Dyck","year":"1974","unstructured":"Dyck PJ, Curtis DJ, Bushek W, Offord K: Description of \"Minnesota Thermal Disks\" and normal values of cutaneous thermal discrimination in man. Neurology. 1974, 24: 325-330.","journal-title":"Neurology"},{"key":"470_CR87","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1600-0404.1995.tb00485.x","volume":"92","author":"MJ Hilz","year":"1995","unstructured":"Hilz MJ, Zimmermann P, Rosl G, Scheidler W, Braun J, Stemper B, Neundorfer B: Vibrameter testing facilitates the diagnosis of uremic and alcoholic polyneuropathy. Acta Neurol Scand. 1995, 92: 486-490.","journal-title":"Acta Neurol Scand"},{"key":"470_CR88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2350-3-10","volume":"3","author":"DP Germain","year":"2002","unstructured":"Germain DP, Avan P, Chassaing A, Bonfils P: Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet. 2002, 3: 10-","journal-title":"BMC Med Genet"},{"key":"470_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","volume":"123","author":"R Rolke","year":"2006","unstructured":"Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Botefur IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihofner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B: Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006, 123: 231-243. 10.1016\/j.pain.2006.01.041.","journal-title":"Pain"},{"key":"470_CR90","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10897-007-9128-x","volume":"17","author":"DA Laney","year":"2008","unstructured":"Laney DA, Fernhoff PM: Diagnosis of Fabry disease via analysis of family history. J Genet Couns. 2008, 17: 79-83. 10.1007\/s10897-007-9128-x.","journal-title":"J Genet Couns"},{"key":"470_CR91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/mus.880110106","volume":"11","author":"PJ Dyck","year":"1988","unstructured":"Dyck PJ: Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988, 11: 21-32. 10.1002\/mus.880110106.","journal-title":"Muscle Nerve"},{"key":"470_CR92","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1212\/WNL.45.6.1115","volume":"45","author":"PJ Dyck","year":"1995","unstructured":"Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC: Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995, 45: 1115-1121.","journal-title":"Neurology"},{"key":"470_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1025127723729","volume":"26","author":"M Ries","year":"2003","unstructured":"Ries M, Mengel E, Kutschke G, Kim KS, Birklein F, Krummenauer F, Beck M: Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. J Inherit Metab Dis. 2003, 26: 413-414. 10.1023\/A:1025127723729.","journal-title":"J Inherit Metab Dis"},{"key":"470_CR94","doi-asserted-by":"crossref","first-page":"166","DOI":"10.33588\/rn.4903.2009100","volume":"49","author":"J Politei","year":"2009","unstructured":"Politei J: Intravenous lidocaine as treatment for the painful episodes in Fabry's disease. Rev Neurol. 2009, 49: 166-167.","journal-title":"Rev Neurol"},{"key":"470_CR95","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.39.4.598","volume":"39","author":"MR Filling-Katz","year":"1989","unstructured":"Filling-Katz MR, Merrick HF, Fink JK, Miles RB, Sokol J, Barton NW: Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction. Neurology. 1989, 39: 598-600.","journal-title":"Neurology"},{"key":"470_CR96","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G: Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010, 9: 807-819. 10.1016\/S1474-4422(10)70143-5.","journal-title":"Lancet Neurol"},{"key":"470_CR97","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1468-1331.2010.02969.x","volume":"17","author":"G Cruccu","year":"2010","unstructured":"Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD: EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010, 17: 1010-1018. 10.1111\/j.1468-1331.2010.02969.x.","journal-title":"Eur J Neurol"},{"key":"470_CR98","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD: Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic proceedings. 2010, 85: S3-14.","journal-title":"Mayo Clinic proceedings"},{"key":"470_CR99","unstructured":"Neuropathic pain: The pharmacological management of neuropathic pain in adults in non-specialist settings (NICE clinical guideline 96). 2010, Centre for Clinical Practice at NICE, [ http:\/\/guidance.nice.org.uk\/CG96 ]"},{"key":"470_CR100","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR: Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006, 8: 539-548. 10.1097\/01.gim.0000237866.70357.c6.","journal-title":"Genet Med"},{"key":"470_CR101","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/0002-9343(80)90224-7","volume":"68","author":"DM Rosenberg","year":"1980","unstructured":"Rosenberg DM, Ferrans VJ, Fulmer JD, Line BR, Barranger JA, Brady RO, Crystal RG: Chronic airflow obstruction in Fabry's disease. Am J Med. 1980, 68: 898-905. 10.1016\/0002-9343(80)90224-7.","journal-title":"Am J Med"},{"key":"470_CR102","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10545-009-1156-2","volume":"32","author":"JM Politei","year":"2009","unstructured":"Politei JM: Can we use statins to prevent stroke in Fabry disease?. J Inherit Metab Dis. 2009, 32: 481-487. 10.1007\/s10545-009-1156-2.","journal-title":"J Inherit Metab Dis"},{"key":"470_CR103","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","volume":"69","author":"F Breunig","year":"2006","unstructured":"Breunig F, Weidemann F, Strotmann J, Knoll A, Wanner C: Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int. 2006, 69: 1216-1221. 10.1038\/sj.ki.5000208.","journal-title":"Kidney Int"},{"key":"470_CR104","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1086\/318809","volume":"68","author":"CM Eng","year":"2001","unstructured":"Eng CM, Banikazemi M, Gordon RE, Goldman M, Phelps R, Kim L, Gass A, Winston J, Dikman S, Fallon JT, Brodie S, Stacy CB, Mehta D, Parsons R, Norton K, O'Callaghan M, Desnick RJ: A phase 1\/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet. 2001, 68: 711-722. 10.1086\/318809.","journal-title":"Am J Hum Genet"},{"key":"470_CR105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ: Safety and efficacy of recombinant human alpha-galactosidase A--replacement therapy in Fabry's disease. N Engl J Med. 2001, 345: 9-16. 10.1056\/NEJM200107053450102.","journal-title":"N Engl J Med"},{"key":"470_CR106","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10545-005-0575-y","volume":"28","author":"Y Eto","year":"2005","unstructured":"Eto Y, Ohashi T, Utsunomiya Y, Fujiwara M, Mizuno A, Inui K, Sakai N, Kitagawa T, Suzuki Y, Mochizuki S, Kawakami M, Hosoya T, Owada M, Sakuraba H, Saito H: Enzyme replacement therapy in Japanese Fabry disease patients: the results of a phase 2 bridging study. J Inherit Metab Dis. 2005, 28: 575-583. 10.1007\/s10545-005-0575-y.","journal-title":"J Inherit Metab Dis"},{"key":"470_CR107","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1681\/ASN.2006080816","volume":"18","author":"DP Germain","year":"2007","unstructured":"Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, Lee P, Loew T, Vedder AC, Abichandani R, Wilcox WR, Guffon N: Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol. 2007, 18: 1547-1557. 10.1681\/ASN.2006080816.","journal-title":"J Am Soc Nephrol"},{"key":"470_CR108","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.medcli.2009.07.053","volume":"134","author":"JM Politei","year":"2010","unstructured":"Politei JM, Dubrovsky A: [Utility of enzyme replacement therapy in Fabry disease]. Medicina Clinica. 2010, 134: 402-405. 10.1016\/j.medcli.2009.07.053.","journal-title":"Medicina Clinica"},{"key":"470_CR109","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mus.10497","volume":"28","author":"R Schiffmann","year":"2003","unstructured":"Schiffmann R, Floeter MK, Dambrosia JM, Gupta S, Moore DF, Sharabi Y, Khurana RK, Brady RO: Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve. 2003, 28: 703-710. 10.1002\/mus.10497.","journal-title":"Muscle Nerve"},{"key":"470_CR110","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO: Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001, 285: 2743-2749. 10.1001\/jama.285.21.2743.","journal-title":"JAMA"},{"key":"470_CR111","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","volume":"2","author":"AC Vedder","year":"2007","unstructured":"Vedder AC, Linthorst GE, Houge G, Groener JE, Ormel EE, Bouma BJ, Aerts JM, Hirth A, Hollak CE: Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg\/kg. PLoS ONE. 2007, 2: e598-10.1371\/journal.pone.0000598.","journal-title":"PLoS ONE"},{"key":"470_CR112","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1086\/422366","volume":"75","author":"WR Wilcox","year":"2004","unstructured":"Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP: Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet. 2004, 75: 65-74. 10.1086\/422366.","journal-title":"Am J Hum Genet"},{"key":"470_CR113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ: Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med. 2007, 146: 77-86.","journal-title":"Ann Intern Med"},{"key":"470_CR114","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Stork S, Voelker W, Ertl G, Wanner C, Strotmann J: Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009, 119: 524-529. 10.1161\/CIRCULATIONAHA.108.794529.","journal-title":"Circulation"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-11-61\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:49:17Z","timestamp":1741193357000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-11-61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,27]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-11-61","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,27]]},"article-number":"61"}}